Autopsy report · NCT00804050

Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

“Difficulties of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months after it had already started.
• Ran for about 3 years before it stopped.
• 184 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Fondazione Italiana Sindromi Mielodisplastiche-ETS

Sponsor type

University, hospital or other

Conditions

Myelodysplastic Syndromes

Interventions

infusion A: rEPO; B Infusion rEPO combined with vitamins pills

Participants

184 (planned, not actual)

Sites

18

Countries

Italy

Trials that died the same way

• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (98% match in meaning)
• Maintenance Dosing of Vitamin D in Crohn's Disease
  “Difficulties with enrollment” (98% match in meaning)
• A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
  “difficulty in enrollment” (96% match in meaning)
• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (93% match in meaning)
• Extended Treatment With Vancomycin for Clostridium Difficile Colitis
  “Difficult enrollment” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.